Stigmasterol stimulates transintestinal cholesterol excretion independent of liver X receptor activation in the small intestine

Despite advances in healthcare, cardiovascular disease (CVD) remains the leading cause of death in the United States. Elevated levels of plasma cholesterol are highly predictive of CVD and stroke and are the principal driver of atherosclerosis. Unfortunately, current cholesterol lowering agents, suc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Nutr Biochem
Egile Nagusiak: Lifsey, Hannah C., Kaur, Rupinder, Thompson, Bradley H, Bennett, Lisa, Temel, Ryan E., Graf, Gregory A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7199294/
https://ncbi.nlm.nih.gov/pubmed/31759199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jnutbio.2019.108263
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak